Anti-cancer

Bendamustine HCl

Also known as: Bendamustine Hydrochloride

CAS No. 3543-75-7

A bifunctional alkylating agent used in injectable oncology formulations for chronic lymphocytic leukemia and non-Hodgkin lymphoma.

Bendamustine HCl is an alkylating agent oncology API manufactured by NovaAcura Biotech under GMP-compliant conditions appropriate to cytotoxic API handling. The company supplies full batch documentation and regulatory support to global oncology formulation partners.

Applications & Uses

A bifunctional alkylating agent used in injectable oncology formulations for chronic lymphocytic leukemia and non-Hodgkin lymphoma.

Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.

Need This Molecule at Scale?

Get in touch for pricing, lead times and full regulatory documentation.

Get In Touch